Bicycle Therapeutics (BCYC) Non-Current Assets (2018 - 2026)

Bicycle Therapeutics' Non-Current Assets history runs 9 years deep, the most recent figure standing at $33.3 million for Q1 2026.

• Quarterly Non-Current Assets rose 19.61% year-over-year to $33.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121.0 million (up 4.59% YoY) and the FY2025 annual result came in at $34.7 million, up 22.82% from the prior year.
• Non-Current Assets was $33.3 million for Q1 2026 at Bicycle Therapeutics, down from $34.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $47.5 million in Q1 2023 and bottomed at $25.1 million in Q3 2025.
• A 5-year average of $33.8 million and a median of $33.3 million in 2026 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets surged 347.81% — and 2024, when it slumped 36.38%.
• Bicycle Therapeutics' Non-Current Assets stood at $41.2 million in 2022, then fell by 18.8% to $33.5 million in 2023, then fell by 15.57% to $28.3 million in 2024, then gained by 22.82% to $34.7 million in 2025, then dropped by 4.18% to $33.3 million in 2026.
• Business Quant data shows BCYC's Non-Current Assets at $33.3 million in Q1 2026, $34.7 million in Q4 2025, and $25.1 million in Q3 2025.